Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL)

M. Mansour Ceesay, Estella Matutes, Graham P. Taylor, Paul Fields, Jamie Cavenagh, Sylwia Simpson, Aloysius Ho, Stephen Devereux, Ghulam J. Mufti, Antonio Pagliuca*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL)'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science